openPR Logo
Press release

Latest Report: Chondrosarcoma Treatment Market, Forecast 2016 - 2022

Latest Report: Chondrosarcoma Treatment Market, Forecast 2016

Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of American Cancer Society, occurrence of chondrosarcoma in patients younger than 20 years is less than 5%. Chondrosarcoma mainly affects the cartilage of arms, ribs, pelvis, and scapula and rarely found in trachea, breast and other parts of the body showing presence of cartilage tissue. Chondrosarcoma patients do not show any symptoms at an early stage hence, it can only be diagnosed in the late stage of a tumor when it shows fracture and bony bump at the tumor site. Diagnosis of chondrosarcoma can be done using radiography (X-Ray), computerized tomography (CT scan) or magnetic resonance imaging (MRI). Unlike other cancers chondrosarcoma is resistant to chemotherapy and radiation therapy and can primarily be treated with surgery. Surgical procedures for chondrosarcoma treatment involve limb sparing operations, complete surgical ablation and amputation in certain cases.

Increasing prevalence of osteosarcoma can ultimately influence the growth of global chondrosarcoma treatment market. According to Cancer Network Journal the incidence of osteosacrcoma in the U.S. is approximately 800 cases per year. Other factors responsible for growth of global chondrosarcoma treatment market include growing prevalence of genetic diseases. However, the global chondrosarcoma treatment market is expected to experience moderate growth during the forecast period owing to limited availability of treatment options.

The global chondrosarcoma treatment market has been classified on the basis of treatment type, end user and geography.

Based on treatment type, the global chondrosarcoma treatment market is divided into following:

Surgical Treatment
Chemotherapy
Radiation therapy

Based on the end user type, the global chondrosarcoma treatment market is divided into following:

Hospitals
Multispecialty Clinics
Cancer Treatment Centers

Surgical treatment segment is expected to lead the global chondrosarcoma treatment market as it is the only efficient treatment option for chondrosarcoma. Radiation therapy and chemotherapy can be used to avoid recurrence of the disease after the surgery. Hospital end user segment is anticipated to contribute large share in global chondrosarcoma treatment market due to requirement of advanced healthcare infrastructure for the procedure.

Geographically, global chondrosarcoma treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to lead the global chondrosarcoma treatment market owing to high incidence rate of the disease. In U.S., chondrosarcoma accounts for almost one third of the primary osteosarcoma cases diagnosed annually.

Request Brochure of this Report: http://www.persistencemarketresearch.com/samples/10100

Top players in global Chondrosarcoma Treatment Market include Hoffmann-La Roche Ltd., AEterna Zentaris Inc., Acorn Research Group, Agios Pharmaceuticals, Inc., Infinity Pharmaceuticals, Inc. and others.

Request to view TOC: http://www.persistencemarketresearch.com/toc/10100

About Us:
Persistence Market Research (PMR) is an innovative provider of market research reports and consulting services. The three PMR pillars of strength that have helped us win clients for years are: Quality Research, Quick Research, and In-depth Research.

PMR’s team of seasoned analysts and consultants are experts in their domain. At PMR, we process complex, exhaustive primary and secondary research data into valuable insight. We Understand that each client has a unique problem statement, and address it with our strengths.

Contact:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest Report: Chondrosarcoma Treatment Market, Forecast 2016 - 2022 here

News-ID: 339935 • Views:

More Releases from Persistence Market Research Pvt. Ltd

Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Market to Hit Surpass US$ 679.6 Million by 2032
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032. The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthetic Lasers Market
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism. Stay Ahead with Market Intelligence Get Free
Predictive Insights for Precision Medicine: The Global Biosimulation Market is Set to Hit USD 10 billion by 2030
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.  Market Overview The biosimulation market has experienced rapid growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheelchairs to Boost Growth
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961 The global wheelchair and components market has witnessed significant growth in

All 5 Releases


More Releases for Chondrosarcoma

Chondrosarcoma Treatment Market to Witness Increase in Revenues by 2022
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of
Chondrosarcoma-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Chondrosarcoma-Pipeline Review H1 2017” this report provides an overview of the Chondrosarcoma-Pipeline landscape. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Pipeline Review, H1 2017, provides an overview of the Chondrosarcoma (Oncology) pipeline landscape. Chondrosarcoma is a malignant cancer whose tumor cells produce a pure hyaline cartilage that results in abnormal bone and/or cartilage growth. Signs and symptoms include pain in the affected
Chondrosarcoma Market Everywhere Leading To Rise in Demand Till 2023
The report for Global Chondrosarcoma Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro
Chondrosarcoma Treatment Market Rugged Expansion Foreseen by 2022
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of
Chondrosarcoma - Pipeline Review, H1 2017 - Pharmaceutical Market Report
Chondrosarcoma is a malignant cancer whose tumor cells produce a pure hyaline cartilage that results in abnormal bone and/or cartilage growth. Signs and symptoms include pain in the affected area that may worsen at night or during physical activity, swelling in the painful area, a lump or mass, enlargement of an existing growth, limping, difficulty moving the affected limb, changes in urination. Treatment includes chemotherapy and radiation therapy. Request Free Sample
Future of Global Chondrosarcoma Treatment Market : 2016 - 2022
Chondrosarcoma refers to cancer of cartilage, a flexible connective tissue found in joints between bones, the ear, the rib cage etc. According to Cancer Network Journal, chondrosarcoma contributes to almost half of the osteosarcoma cases and is the second most common type of osteosacrcoma (tumor of bones). Chondrosarcoma can start at any age but most commonly found in adults above the age of 20 years. As per the statistics of